PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
23-Sep-2020 Janssen Presents Findings from Global, Multi-Centre Trial Examining Amivantamab in Combination with Lazertinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer The Janssen Pharmaceutical Companies of Johnson & Johnson
23-Sep-2020 Lynparza recommended for approval in EU by CHMP as 1st-line maintenance treatment with bevacizumab for HRD-positive advanced ovarian cancer AstraZeneca
23-Sep-2020 Lynparza recommended for approval in the EU by CHMP for BRCA-mutated metastatic castration-resistant prostate cancer AstraZeneca
23-Sep-2020 Lynparza reduced the risk of death by 31% in BRCA1/2 or ATM-mutated metastatic castration-resistant prostate cancer in PROfound Phase III trial AstraZeneca
23-Sep-2020 Switching to investigational once-weekly insulin icodec from other basal insulins demonstrated to be efficacious and well-tolerated for people with type 2 diabetes in phase 2 trial Novo Nordisk
23-Sep-2020 Preliminary Results for the year ended 30 June 2020 Allergy Therapeutics plc
23-Sep-2020 PureTech Plans U.S. Listing on Nasdaq Global Market PureTech Health
23-Sep-2020 Helsinn supports the PhD program 2020-2021 of the Institute of Oncology Research (IOR) of the Faculty of Biomedical Sciences at the Università della Svizzera italiana (USI) Helsinn
23-Sep-2020 UCB Achieves Important Regulatory Milestone for Bimekizumab UCB
23-Sep-2020 Thomas International launches new Talent Assessment Platform Thomas International
23-Sep-2020 Pain Management Drugs Market to Reach $85.54 Bn, Globally, by 2027 at 3.9% CAGR: Allied Market Research Allied Market Research
23-Sep-2020 Neurelis Announces Program To Investigate The Safety And Pharmacokinetics Of VALTOCO® (Diazepam Nasal Spray) In Children Aged 2 To 5 Neurelis, Inc.
23-Sep-2020 Neurelis Announces Program To Investigate The Safety And Pharmacokinetics Of VALTOCO® (Diazepam Nasal Spray) In Children Aged 2 To 5 Neurelis, Inc.
23-Sep-2020 Ardigen has received funding to accelerate its AI-driven TCR discovery platform for novel cell therapies Ardigen SA
23-Sep-2020 Collagen Market Worth $7.53 Billion by 2027- Exclusive Report Covering Pre and Post COVID-19 Market Analysis by Meticulous Research® Meticulous Market Research Pvt. Ltd
23-Sep-2020 New Study Indicates that KUBTEC's Mozart® 3D Specimen Imaging Decreases Re-Excision Rates for Breast Lumpectomies By More Than 50% Kubtec
23-Sep-2020 Ardigen has received funding to accelerate its AI-driven TCR discovery platform for novel cell therapies Ardigen SA
23-Sep-2020 New Study Indicates that KUBTEC's Mozart® 3D Specimen Imaging Decreases Re-Excision Rates for Breast Lumpectomies By More Than 50% Kubtec
23-Sep-2020 New Study Indicates that KUBTEC's Mozart® 3D Specimen Imaging Decreases Re-Excision Rates for Breast Lumpectomies By More Than 50% Kubtec
23-Sep-2020 CDI Labs HuProt(TM) Protein arrays instrumental in recent study of Multisystem Inflammatory Syndrome in Children (MIS-C) CDI Laboratories